Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Ottawa

$49,800.00

A Rapid and Highly Sensitive On-site Detection Platform for COVID-19 Testing_x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_

FY 2020-21

Summary
The COVID-19 pandemic has caused more than 2.4 million infections and more 166,000 deaths worldwide to date, and it is not showing any signs of slowing down. While public health workers are working around the clock to identify new cases of COVID-19 infections, a clear bottleneck - lack of fast tasting capacity to keep up with the rate of infection - has been severely exposed. This problem is exacerbated by emerging evidence suggesting that approximately 50% to 85% of COVID-19 patients, who are either asymptomatic or pre-symptomatic, are still able to transmit the virus and infect others undetected, making it even more difficult to keep track of the disease in order to contain it, an unfortunate situation that can only be described as "flying blind". The goal of the current Alliance COVID-19 application is to develop a surface plasmon resonance (SPR) based ultra-sensitive detection platform that will detect the presence of SARS-CoV-2 virus from swabbed samples without the need for any sample preparations. We expect that the test results can be available within 10 minutes. For this proposed detection platform to be successful, innovative designs to enhance detection sensitivity must be carefully considered. To this end, we propose to surface modify the SPR detection chip so that 1) the detection surface is rendered nonfouling to reduce nonspecific bindings to minimize the background noise, and 2) the efficacy of the detection surface to capture target SARS-CoV-2 viruses is enhanced in order to increase detection signals. We expect that the test results can be available within 10 minutes with a limit of detection at about 10^4 viruses/mL, similar to that of the PCR. The estimated cost of the test is about $20/test.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
550114-2020
Name nom
Cao, Xudong
Department département
Chemical and Biological Engineering
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
49800
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
A Rapid and Highly Sensitive On-site Detection Platform for COVID-19 Testing_x000d_ _x000d_ _x000d_ _x000d_ _x000d_ _x000d_
Keyword
NSERC
Application summary
The COVID-19 pandemic has caused more than 2.4 million infections and more 166,000 deaths worldwide to date, and it is not showing any signs of slowing down. While public health workers are working around the clock to identify new cases of COVID-19 infections, a clear bottleneck - lack of fast tasting capacity to keep up with the rate of infection - has been severely exposed. This problem is exacerbated by emerging evidence suggesting that approximately 50% to 85% of COVID-19 patients, who are either asymptomatic or pre-symptomatic, are still able to transmit the virus and infect others undetected, making it even more difficult to keep track of the disease in order to contain it, an unfortunate situation that can only be described as "flying blind". The goal of the current Alliance COVID-19 application is to develop a surface plasmon resonance (SPR) based ultra-sensitive detection platform that will detect the presence of SARS-CoV-2 virus from swabbed samples without the need for any sample preparations. We expect that the test results can be available within 10 minutes. For this proposed detection platform to be successful, innovative designs to enhance detection sensitivity must be carefully considered. To this end, we propose to surface modify the SPR detection chip so that 1) the detection surface is rendered nonfouling to reduce nonspecific bindings to minimize the background noise, and 2) the efficacy of the detection surface to capture target SARS-CoV-2 viruses is enhanced in order to increase detection signals. We expect that the test results can be available within 10 minutes with a limit of detection at about 10^4 viruses/mL, similar to that of the PCR. The estimated cost of the test is about $20/test.